Target intelligence / Profile preview

Secretin receptor family (class B G protein-coupled receptor family)

Molecular classification
G protein-coupled receptor, Receptor
01

Overview

The **Secretin receptor family** (class B G protein-coupled receptor family) consists of structurally related cell surface receptors that respond primarily to peptide hormones of the glucagon hormone family, including secretin, glucagon, glucagon-like peptide 1, vasoactive intestinal peptide, calcitonin, parathyroid hormone, and others[1][2][3]. Members share a seven transmembrane domain architecture with a large extracellular N-terminal domain crucial for peptide hormone binding[1][2][3]. These receptors are critical mediators of various physiological responses, such as glucose metabolism, insulin secretion, bone turnover, cardiovascular regulation, and stress response, acting via activation of adenylyl cyclase and the phosphatidyl-inositol-calcium pathway[1][2][3][5]. The family comprises defined subgroups (notably subfamily B1, which includes "classical" hormone receptors such as the GLP-1 receptor, glucagon receptor, secretin receptor, and parathyroid hormone receptor)[1][2]. Due to their strong involvement in metabolic, endocrine, and cardiovascular disorders, these receptors are major targets for numerous approved drugs[2][5]. **Note:** The name "Secretin receptor family" refers to a molecular receptor family—a group of related drug targets—not a single molecular entity. For structured data, it is preferable to reference specific family members (e.g., "Glucagon-like peptide 1 receptor") rather than the family as a whole[1][2][3][5].

Other names
Class B G protein-coupled receptorsSecretin-like receptor familyFamily B GPCRsFamily 2 GPCRs
02

Mechanism of action

Agonism or antagonism at peptide hormone receptors to modulate cAMP and phosphatidylinositol-calcium pathway signaling

03

Biological functions

Signal transductionHormone signalingCell communicationRegulation of metabolic processes
04

Disease associations

DiabetesObesityOsteoporosisCardiovascular diseaseNeuroendocrine disordersCancer
05

Safety considerations

Off-target effects due to pleiotropic expression of family membersUnintended metabolic or cardiovascular changes by non-selective modulationChallenges in achieving selective targeting due to homology among family members
06

Interacting drugs

GLP-1 receptor agonists (e.g., exenatide, liraglutide, semaglutide)

5 more in the full profile.

07

Biomarkers

Expression levels of specific family members (e.g., GLP-1 receptor, parathyroid hormone receptor) as biomarkers for diseases such as diabetes or osteoporosis

Beyond the preview

Go deeper on Secretin receptor family (class B G protein-coupled receptor family).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Secretin receptor family (class B G protein-coupled receptor family).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call